Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Radiological and Functional Pulmonary Evolution in Post-COVID-19 Patients: An Observational Study

Version 1 : Received: 26 July 2023 / Approved: 27 July 2023 / Online: 28 July 2023 (12:48:47 CEST)

A peer-reviewed article of this Preprint also exists.

Cavallari Strozze Catharin, V.M.; Zutin, T.L.M.; Guiguer, E.L.; Cressoni Araújo, A.; Fornari Laurindo, L.; Chagas, E.F.B.; Gasparotti Zorzetto, C.F.; Bueno, P.C.S.; dos Santos Bueno, M.; Cervelim Nunes, Y.; Cavallari Strozze Catharin, V.; Gonzaga, H.F.; Barbalho, S.M. Radiological and Functional Pulmonary Evolution in Post-COVID-19 Patients: An Observational Study. Diseases 2023, 11, 113. Cavallari Strozze Catharin, V.M.; Zutin, T.L.M.; Guiguer, E.L.; Cressoni Araújo, A.; Fornari Laurindo, L.; Chagas, E.F.B.; Gasparotti Zorzetto, C.F.; Bueno, P.C.S.; dos Santos Bueno, M.; Cervelim Nunes, Y.; Cavallari Strozze Catharin, V.; Gonzaga, H.F.; Barbalho, S.M. Radiological and Functional Pulmonary Evolution in Post-COVID-19 Patients: An Observational Study. Diseases 2023, 11, 113.

Abstract

COVID-19 generated a scenario for global health with multiple systemic impairments. This retrospective study evaluated the clinical, radiological, and pulmonary functional evolution in 302 post-COVID-19 patients. Regarding post-COVID-19 pulmonary symptoms, dry cough, dyspnea, and chest pain were the most frequent. Of the associated comorbidities, asthma was more frequent (23.5%). Chest Tomography (CT) initially showed a mean pulmonary involvement of 69.7%, and the evaluation in the subsequent months showed an improvement in the evolutionary image, and with less than six months post-pathology, there was a commitment of 37 .7%, from six to twelve months, 20% and after 12 months, 9.9%. And as for most of the sample, 50.3% of the patients presented CT normalization in less than six months after infection, 23% normalized between six and twelve months, and 5.2% normalized the images after twelve months, with one remaining. Percentage of 17.3% who maintained post-COVID-19 pulmonary residual sequelae. Regarding spirometry, in less than six months after the pathology, 59.3% of the patients already showed a regular exam; 12.3% normalized their function within six to twelve months, and 6.3% concluded a normal exam after twelve months of post-pathology evaluation. Only 3.6% of the patients still showed some alteration in this period.

Keywords

COVID-19; post-COVID-19; pulmonary manifestations; spirometry; chest tomography.

Subject

Public Health and Healthcare, Public Health and Health Services

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.